Related Content
Download content relating to this event and topic.
Biologics World Southeast Asia 2026 brings together senior decision-makers across biopharma, biotech, and manufacturing to drive innovation, scale-up, and commercialisation of therapeutic biologics across the ASEAN region

Biologics World Southeast Asia is a premier regional platform dedicated to advancing the development, manufacturing, and commercialisation of therapeutic biologics across ASEAN. The conference convenes senior leaders from biopharma, biotech, CDMOs, academia, regulators, investors, and technology providers to address the strategic opportunities shaping Southeast Asia’s biologics landscape.
As demand for monoclonal antibodies, biosimilars, and next-generation biologics continues to rise across the region, Southeast Asia is emerging as a critical hub for clinical development, manufacturing expansion, and healthcare innovation. Governments across Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the wider ASEAN region are accelerating investments into life sciences infrastructure, regulatory strengthening, and local production capabilities to enhance healthcare resilience and reduce reliance on imports.
The conference explores the full therapeutic biologics value chain — from R&D and translational science to bioprocessing, manufacturing scale-up, CDMO partnerships, and market access. Through strategic discussions and real-world case studies, the programme highlights regional capabilities, investment priorities, and collaboration opportunities driving the growth of biologics adoption in Southeast Asia.
Biologics World Southeast Asia is co-located with the Vaccine World Southeast Asia Congress, creating a unified platform that brings together stakeholders across the broader biopharmaceutical ecosystem. While the Vaccine Congress focuses on infectious diseases, immunisation strategies, and vaccine innovation, Biologics World Southeast Asia maintains a dedicated emphasis on therapeutic biologics, including monoclonal antibodies, biosimilars, antibody-drug conjugates (ADCs), and protein therapeutics.
This co-located format enables cross-industry exchange while preserving distinct scientific and commercial discussions, fostering stronger partnerships across research, manufacturing, and healthcare delivery.
By convening global and regional decision-makers under one platform, Biologics World Southeast Asia aims to support Southeast Asia’s transformation into a competitive biologics hub - strengthening manufacturing capabilities, improving patient access to advanced therapies, and positioning ASEAN as a key contributor within the global biologics value chain.

View the Key Themes for
Biologics World South East Asia 2026
Register today to secure your ticket.
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Apply to SpeakSelect the relevant ticket for your organisation.
*Delegate tickets must be purchased under the correct classification.
Biopharma tickets are strictly reserved for professionals employed by pharmaceutical or biopharmaceutical companies that develop, own, or commercialise therapeutic drug products, including organisations with an internal drug pipeline spanning discovery, development, clinical, or commercial stages. This category applies to companies whose primary business is the development or manufacture of drug products, not the provision of enabling technologies, equipment, platforms, or services.
Service, Solution, and Technology Provider tickets apply to all organisations offering services, platforms, technologies, equipment, consultancy, manufacturing services, or commercial solutions to the pharma and biopharma industry. This includes, but is not limited to, CROs, CDMOs, technology and equipment vendors, consultants, suppliers, and solution providers, regardless of scientific or technical focus.
Important Notice
All registrations are reviewed to ensure correct classification. Purchasing an incorrect ticket does not guarantee entry to the event. IMAPAC retains full discretion to deny access, reclassify registrations, and issue an invoice for the price difference required for correct attendance. Incorrect ticket purchases made under an inappropriate classification are not eligible for refunds under any circumstances, including where the registrant chooses not to upgrade or attend.
Limited Super
*PRICING IS APPLICABLE to:
Company Profiles: Biopharma, BIG Pharmas, Academic& Research Institutes
Applicable Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations
Limited Super
*PRICING IS APPLICABLE to:
Company Profiles: Biopharma, BIG Pharmas, Academic& Research Institutes
Applicable Job Profiles: Manufacturing,Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance andProduct Manufacturing, Process Development, Quality, Analytics and otherrelated technical designations
Limited Super
*PRICING IS APPLICABLE to:
Company Profiles: Service & Solution Providers, International biopharma, Big Pharma, CDMO/CMOs, Academics and Research Institutes*
Applicable Job Profiles: Business Development, Marketing & Sales
Be the first in line!
Register your interest to get access to tickets as soon as they go live.
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Visit the event page to view more content.
Download content relating to this event and topic.
Visit the event page to view more content.
Visit the awards page to view more content.
To stay informed about event updates, including date, venue, and agenda, please subscribe to our our official social media channels for real-time updates and announcements.
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Yes, we offer sponsorship and exhibition opportunities for businesses and organisations.
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Don't miss out on unique networking, speaking and sponsorship opportunities.